{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:01:51Z","timestamp":1793293311327,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Tumor Biology Laboratory","award":["2022-2.1.1-NL-2022-00010"],"award-info":[{"award-number":["2022-2.1.1-NL-2022-00010"]}]},{"name":"Hungarian Thematic Excellence Program","award":["TKP2021-EGA-44"],"award-info":[{"award-number":["TKP2021-EGA-44"]}]},{"name":"National Institute of Oncology","id":[{"id":"https:\/\/ror.org\/02kjgsq44","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>In 2020, bladder cancer (BC) was the seventh most prevalent cancer in the world, with 5-year prevalence of more than 1.7 million cases. Due to the main risk factors\u2014smoking and chemical exposures\u2014associated with BC, it is considered a largely preventable and avoidable cancer. An overview of BC mortality can allow an insight not only into the prevalence of global risk factors, but also into the varying efficiency of healthcare systems worldwide. For this purpose, this study analyzes the national mortality estimates for 2020 and projected future trends up to 2040.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Age-standardized mortality rates per 100,000 person-years of BC for 185 countries by sex were obtained from the GLOBOCAN 2020 database, operated by the International Agency for Research on Cancer (IARC). Mortality rates were stratified according to sex and Human Development Index (HDI). BC deaths were projected up to 2040 on the basis of demographic changes, alongside different scenarios of annually increasing, stable or decreasing mortality rates from the baseline year of 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2020, nearly three times more men died from BC than women, with more than 210,000 deaths in both sexes combined, worldwide. Regardless of gender, more than half of the total BC deaths were from countries with a very high HDI. According to our projections, while the number of deaths for men can only increase up to 54% (from 159 to around 163\u2013245 thousand), for women it is projected to increase two- to three-fold (from 50 to around 119\u2013176 thousand) by 2040. The burden of BC mortality in countries with a very high HDI versus high HDI appears to converge by 2040 for both sexes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Opposite mortality trends by gender highlight the urgent need for immediate interventions to expand anti-tobacco strategies, especially for women. The implementation of more strict occupational health and safety regulations could also prevent exposures associated with BC. Improving the ability to detect BC earlier and access to treatment can have a significant positive impact on reducing mortality rates, minimizing economic costs, and enhancing the quality of life for patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00345-024-04949-8","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T07:14:15Z","timestamp":1713251655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN estimates"],"prefix":"10.1007","volume":"42","author":[{"given":"Andr\u00e1s","family":"W\u00e9ber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Vignat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Laversanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Kenessey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Znaor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"4949_CR1","unstructured":"Cancer Today (n.d.). http:\/\/gco.iarc.fr\/today\/home. Accessed April 13, 2022"},{"key":"4949_CR2","unstructured":"Survival Rates for Bladder Cancer (n.d.). https:\/\/www.cancer.org\/cancer\/bladder-cancer\/detection-diagnosis-staging\/survival-rates.html. Accessed May 20, 2021"},{"key":"4949_CR3","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.ejca.2015.07.028","volume":"51","author":"R Marcos-Gragera","year":"2015","unstructured":"Marcos-Gragera R, Mallone S, Kiemeney LA, Vilardell L, Malats N, Allory Y, Sant M, Hackl M, Zielonke N, Oberaigner W, Van Eycken E, Henau K, Valerianova Z, Dimitrova N, Sekerija M, Zvolsk\u00fd M, Du\u0161ek L, Storm H, Engholm G, M\u00e4gi M, Aareleid T, Malila N, Sepp\u00e4 K, Velten M, Troussard X, Bouvier V, Launoy G, Guizard AV, Faivre J, Bouvier AM, Arveux P, Maynadi\u00e9 M, Woronoff AS, Robaszkiewicz M, Baldi I, Monnereau A, Tretarre B, Bossard N, Belot A, Colonna M, Molini\u00e9 F, Bara S, Schvartz C, Lap\u00f4tre-Ledoux B, Grosclaude P, Meyer M, Stabenow R, Luttmann S, Eberle A, Brenner H, Nennecke A, Engel J, Schubert-Fritschle G, Kieschke J, Heidrich J, Holleczek B, Katalinic A, J\u00f3nasson JG, Tryggvad\u00f3ttir L, Comber H, Mazzoleni G, Bulatko A, Buzzoni C, Giacomin A, Sutera Sardo A, Mazzei A, Ferretti S, Crocetti E, Manneschi G, Gatta G, Sant M, Amash H, Amati C, Baili P, Berrino F, Bonfarnuzzo S, Botta L, Di Salvo F, Foschi R, Margutti C, Meneghini E, Minicozzi P, Trama A, Serraino D, Zucchetto A, De Angelis R, Caldora M, Capocaccia R, Carrani E, Francisci S, Mallone S, Pierannunzio D, Roazzi P, Rossi S, Santaquilani M, Tavilla A, Pannozzo F, Busco S, Bonelli L, Vercelli M, Gennaro V, Ricci P, Autelitano M, Randi G, Ponz De Leon M, Marchesi C, Cirilli C, Fusco M, Vitale MF, Usala M, Traina A, Zarcone M, Vitale F, Cusimano R, Michiara M, Tumino R, Giorgi Rossi P, Vicentini M, Falcini F, Iannelli A, Sechi O, Cesaraccio R, Piffer S, Madeddu A, Tisano F, Maspero S, Fanetti AC, Zanetti R, Rosso S, Candela P, Scuderi T, Stracci F, Rocca A, Tagliabue G, Contiero P, Dei Tos AP, Tognazzo S, Pildava S, Smailyte G, Calleja N, Micallef R, Johannesen TB, Rachtan J, G\u00f3zdz S, Mezyk R, Blaszczyk J, Kepska K, Bielska-Lasota M, Forjaz de Lacerda G, Bento MJ, Antunes L, Miranda A, Mayer-da-Silva A, Nicula F, Coza D, Safaei Diba C, Primic-Zakelj M, Almar E, Mateos A, Errezola M, Larra\u00f1aga N, Torrella-Ramos A, D\u00edaz Garc\u00eda JM, Marcos-Navarro AI, Marcos-Gragera R, Vilardell L, Sanchez MJ, Molina E, Navarro C, Chirlaque MD, Moreno-Iribas C, Ardanaz E, Galceran J, Carulla M, Lambe M, Khan S, Mousavi M, Bouchardy C, Usel M, Ess SM, Frick H, Lorez M, Ess SM, Herrmann C, Bordoni A, Spitale A, Konzelmann I, Visser O, Aben K, Coleman M, Allemani C, Rachet B, Verne J, Easey N, Lawrence G, Moran T, Rashbass J, Roche M, Wilkinson J, Gavin A, Fitzpatrick D, Brewster DH, Huws DW, White C, Otter R (2015) Urinary tract cancer survival in Europe 1999\u20132007: results of the population-based study EUROCARE-5. Eur J Cancer 51:2217\u20132230. https:\/\/doi.org\/10.1016\/j.ejca.2015.07.028","journal-title":"Eur J Cancer"},{"key":"4949_CR4","unstructured":"National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, The Health Consequences of Smoking\u201450 Years of Progress: A Report of the Surgeon General, Centers for Disease Control and Prevention (US), Atlanta (GA), 2014. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK179276\/. Accessed April 14, 2022"},{"key":"4949_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/tc.3.3.242","volume":"3","author":"AD Lopez","year":"1994","unstructured":"Lopez AD, Collishaw NE, Piha T (1994) A descriptive model of the cigarette epidemic in developed countries. Tob Control 3:242\u2013247. https:\/\/doi.org\/10.1136\/tc.3.3.242","journal-title":"Tob Control"},{"key":"4949_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/tobaccocontrol-2011-050294","volume":"21","author":"M Thun","year":"2012","unstructured":"Thun M, Peto R, Boreham J, Lopez AD (2012) Stages of the cigarette epidemic on entering its second century. Tob Control 21:96\u2013101. https:\/\/doi.org\/10.1136\/tobaccocontrol-2011-050294","journal-title":"Tob Control"},{"key":"4949_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber I, Ong S, Bukavina L, Black PC, Comp\u00e9rat E, Kamat AM, Kiemeney L, Lawrentschuk N, Lerner SP, Meeks JJ, Moch H, Necchi A, Panebianco V, Sridhar SS, Znaor A, Catto JWF, Cumberbatch MG (2023) Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol 84:176\u2013190. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.029","journal-title":"Eur Urol"},{"key":"4949_CR8","unstructured":"Jacques Ferlay, Morten Ervik, Frederik Lam, Murielle Colombet, Les Mery, Marion Pineros, Ariana Znaor, Isabelle Soerjomataram, Freddie Bray, Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer (n.d.). https:\/\/gco.iarc.fr\/today"},{"key":"4949_CR9","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, Bray F (2021) Cancer statistics for the year 2020: an overview. Int J Cancer 149:778\u2013789. https:\/\/doi.org\/10.1002\/ijc.33588","journal-title":"Int J Cancer"},{"key":"4949_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4949_CR11","unstructured":"UNSD\u2014Methodology (n.d.). https:\/\/unstats.un.org\/unsd\/methodology\/m49\/. Accessed April 15, 2022"},{"key":"4949_CR12","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pi\u00f1eros M, Znaor A, Bray F (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144:1941\u20131953. https:\/\/doi.org\/10.1002\/ijc.31937","journal-title":"Int J Cancer"},{"key":"4949_CR13","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359-386. https:\/\/doi.org\/10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"4949_CR14","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893\u20132917. https:\/\/doi.org\/10.1002\/ijc.25516","journal-title":"Int J Cancer"},{"key":"4949_CR15","unstructured":"Cancer Mortality for Selected Sites in 24 Countries (1950\u201357)\u2014ScienceOpen (n.d.). https:\/\/www.scienceopen.com\/document?vid=d36053cb-ebfe-4b4c-a7ca-05447aa3cd19. Accessed April 15, 2022"},{"key":"4949_CR16","unstructured":"Schneiderman MA (1968) Cancer incidence in five continents: a technical report. In: Doll R, Payne P, Waterhouse J (eds) Springer, New York, 1966. 244 pp. $9.50, Cancer Research, 28 (1968) 804"},{"key":"4949_CR17","unstructured":"Day NE (1992) Cancer incidence in five continents. Cumulative rate and cumulative risk, IARC Sci Publ., pp 862\u2013864"},{"key":"4949_CR18","unstructured":"Human Development Reports | United Nations Development Programme (n.d.). https:\/\/hdr.undp.org\/. Accessed April 15, 2022"},{"key":"4949_CR19","unstructured":"Jacques Ferlay, Mathieu Laversanne, Morten Ervik, Frederik Lam, Murielle Colombet, Les Mery, Marion Pineros, Ariana Znaor, Isabelle Soerjomataram, Freddie Bray, Global Cancer Observatory: Cancer Tomorrow (n.d.). https:\/\/gco.iarc.fr\/tomorrow"},{"key":"4949_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/oxfordjournals.bmb.a011534","volume":"52","author":"A Amos","year":"1996","unstructured":"Amos A (1996) Women and smoking. Br Med Bull 52:74\u201389. https:\/\/doi.org\/10.1093\/oxfordjournals.bmb.a011534","journal-title":"Br Med Bull"},{"key":"4949_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/tc.9.1.3","volume":"9","author":"A Amos","year":"2000","unstructured":"Amos A, Haglund M (2000) From social taboo to \u201ctorch of freedom\u201d: the marketing of cigarettes to women. Tob Control 9:3\u20138. https:\/\/doi.org\/10.1136\/tc.9.1.3","journal-title":"Tob Control"},{"key":"4949_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12889-020-8148-4","volume":"20","author":"M Wensink","year":"2020","unstructured":"Wensink M, Alvarez J-A, Rizzi S, Janssen F, Lindahl-Jacobsen R (2020) Progression of the smoking epidemic in high-income regions and its effects on male-female survival differences: a cohort-by-age analysis of 17 countries. BMC Public Health 20:39. https:\/\/doi.org\/10.1186\/s12889-020-8148-4","journal-title":"BMC Public Health"},{"key":"4949_CR23","unstructured":"International Agency for Research on Cancer, Improving Early Detection and Clinical Management of Bladder Cancer\u2014A promising urine test (uTERTpm) (2022). https:\/\/www.iarc.who.int\/wp-content\/uploads\/2022\/05\/IARC_Evidence_Summary_Brief_3.pdf"},{"key":"4949_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/MOU.0000000000000198","volume":"25","author":"I Wolff","year":"2015","unstructured":"Wolff I, Brookman-May S, May M (2015) Sex difference in presentation and outcomes of bladder cancer: Biological reality or statistical fluke? Curr Opin Urol 25:418. https:\/\/doi.org\/10.1097\/MOU.0000000000000198","journal-title":"Curr Opin Urol"},{"key":"4949_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1464-410X.2012.11661.x","volume":"112","author":"A Henning","year":"2013","unstructured":"Henning A, Wehrberger M, Madersbacher S, Pycha A, Martini T, Comploj E, Jeschke K, Tripolt C, Rauchenwald M (2013) Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int 112:68\u201373. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11661.x","journal-title":"BJU Int"},{"key":"4949_CR26","unstructured":"Bladder Cancer Survival: Women Better off in the Long Run\u2014Science Direct (n.d.). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0959804918307081?via%3Dihub. Accessed March 13, 2023"},{"key":"4949_CR27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/aje\/kwj028","volume":"163","author":"M McGrath","year":"2006","unstructured":"McGrath M, Michaud DS, De Vivo I (2006) Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol 163:236\u2013244. https:\/\/doi.org\/10.1093\/aje\/kwj028","journal-title":"Am J Epidemiol"},{"key":"4949_CR28","doi-asserted-by":"publisher","first-page":"13006","DOI":"10.1038\/s41598-021-92446-y","volume":"11","author":"E Lynge","year":"2021","unstructured":"Lynge E, Holmsgaard HA, Holmager TLF, Lophaven S (2021) Cancer incidence in Thybor\u00f8n-Harbo\u00f8re, Denmark: a cohort study from an industrially contaminated site. Sci Rep 11:13006. https:\/\/doi.org\/10.1038\/s41598-021-92446-y","journal-title":"Sci Rep"},{"key":"4949_CR29","doi-asserted-by":"crossref","unstructured":"Preventable Exposures Associated With Human Cancers | JNCI: Journal of the National Cancer Institute | Oxford Academic (n.d.). https:\/\/academic.oup.com\/jnci\/article\/103\/24\/1827\/937010. Accessed March 15, 2023","DOI":"10.1093\/jnci\/djr483"},{"key":"4949_CR30","doi-asserted-by":"publisher","first-page":"017001","DOI":"10.1289\/EHP4495","volume":"128","author":"I Evlampidou","year":"2020","unstructured":"Evlampidou I, Font-Ribera L, Rojas-Rueda D, Gracia-Lavedan E, Costet N, Pearce N, Vineis P, Jaakkola JJK, Delloye F, Makris KC, Stephanou EG, Kargaki S, Kozisek F, Sigsgaard T, Hansen B, Schullehner J, Nahkur R, Galey C, Zwiener C, Vargha M, Righi E, Aggazzotti G, Kalnina G, Grazuleviciene R, Polanska K, Gubkova D, Bitenc K, Goslan EH, Kogevinas M, Villanueva CM (2020) Trihalomethanes in drinking water and bladder cancer burden in the European Union. Environ Health Perspect 128:017001. https:\/\/doi.org\/10.1289\/EHP4495","journal-title":"Environ Health Perspect"},{"key":"4949_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/medsci8010015","volume":"8","author":"K Saginala","year":"2020","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A (2020) Epidemiology of bladder cancer. Med Sci 8:15. https:\/\/doi.org\/10.3390\/medsci8010015","journal-title":"Med Sci"},{"key":"4949_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","volume":"69","author":"J Leal","year":"2016","unstructured":"Leal J, Luengo-Fernandez R, Sullivan R, Witjes JA (2016) Economic burden of bladder cancer across the European Union. Eur Urol 69:438\u2013447. https:\/\/doi.org\/10.1016\/j.eururo.2015.10.024","journal-title":"Eur Urol"},{"key":"4949_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00345-009-0395-z","volume":"27","author":"KD Sievert","year":"2009","unstructured":"Sievert KD, Amend B, Nagele U, Schilling D, Bedke J, Horstmann M, Hennenlotter J, Kruck S, Stenzl A (2009) Economic aspects of bladder cancer: What are the benefits and costs? World J Urol 27:295\u2013300. https:\/\/doi.org\/10.1007\/s00345-009-0395-z","journal-title":"World J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-04949-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-024-04949-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-04949-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T16:26:51Z","timestamp":1735835211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-024-04949-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4949"],"URL":"https:\/\/doi.org\/10.1007\/s00345-024-04949-8","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"assertion":[{"value":"16 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not involve human participants and animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"237"}}